Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo under the brand name Tresiba. It is administered via subcutaneous injection to help control the blood sugar level of those with diabetes.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.